Call us at 702-998-8009 for more information
Manufactured by Leeford Healthcare Ltd, this product meets strict quality control standards to provide reliable supplementation
The innovative therapeutic approach employing MLipRIR-NPs combines R162, a glutamate dehydrogenase inhibitor, and the hydrophobic photosensitizer IR780 [206]
Tumilaar SG, Hardianto A, Dohi H, Kurnia D
Overall, G/D-CuP demonstrated superior mechanical properties like self-healing, strong adhesion, high malleability, and ROS responsiveness, making it a promising candidate for complex wound healing therapies
Conversely, high levels of glutathione in the body have been linked to the development of chemotherapy resistance in cancer patients